Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of LivaloV and Drug A in Healthy Volunteers
NCT05351840Phase 1Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Nov 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pitavastatin in dyslipidemia and hypertension (HTN), sponsored by JW Pharmaceutical Corporation. Primary endpoints: Area Under the Concentration-Time Curve at Steady State over Dosing Interval and Maximum Steady State Plasma Concentration. Started Nov 2020; status: completed.
02
Drugs
pitavastatin
03
Conditions
dyslipidemiahypertension (HTN)
Beyond the preview
Go deeper on NCT05351840.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351840.